CAS: 81919-14-4 - Bendazac L-lysine

Formel: C₂₂H₂₈N₄O₅

InChl: InChI=1S/C16H14N2O3.C6H14N2O2/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12;7-4-2-1-3-5(8)6(9)10/h1-9H,10-11H2,(H,19,20);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1

InChI Key: InChIKey=OCOCFNMFLNFNIA-ZSCHJXSPSA-N

SMILES: O=C(O)COC1=NN(C=2C=CC=CC12)CC=3C=CC=CC3.O=C(O)C(N)CCCCN

Synonyme:

• 2,6-diammoniohexanoate [(1-benzyl-1H-indazol-3-yl)oxy]acetate
• <span class="text-smallcaps">L</span>-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
• <span class="text-smallcaps">L</span>-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]
• Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. with <span class="text-smallcaps">L</span>-lysine (1:1)
• Af 1934
• Bendaline
• Bendazac <span class="text-smallcaps">L</span>-lysine salt
• Bendazac lysine
• Bendazac lysine salt
• Bendazaclysine
• L-Lysine-(1-benzyl-1H-indazol-3-yloxy)acetic acid

L-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]OTHER CA INDEX NAMES:Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. withL-lysine (1:1)

CAS: 81919-14-4

• Formel: C₂₂H₂₈N₄O₅
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 428.4815

Bendazac L-lysine

CAS: 81919-14-4

Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the …

• Formel: C₂₂H₂₈N₄O₅
• Reinheit: 99.91%
• Farbe und Form: White
• Molekulargewicht: 428.48

Bendazac-d7 L-lysine

CAS: 81919-14-4

• Formel: C₁₆H₇D₇N₂O₃·C₆H₁₄N₂O₂
• Molekulargewicht: 289.34 146.19

Bendazac L-lysine

CAS: 81919-14-4

• Formel: C₁₆H₁₄N₂O₃·C₆H₁₄N₂O₂
• Molekulargewicht: 282.30 146.19

Bendazac L-Lysine

CAS: 81919-14-4

• Formel: C₁₆H₁₄N₂O₃·C₆H₁₄N₂O₂
• Farbe und Form: Neat
• Molekulargewicht: 428.481

Bendazac L-lysine

CAS: 81919-14-4

Bendazac L-lysine is a coumarin derivative that is used in pharmaceutical preparations for the treatment …

• Formel: C₂₂H₂₈N₄O₅
• Reinheit: Min. 95%
• Molekulargewicht: 428.48 g/mol